Incidence and Clinical Characteristics of Pulmonary Hypertension Secondary to ARDS in the Highland

ARDS Clinical Trial

Official title:

Incidence and Clinical Characteristics of Pulmonary Hypertension Secondary to ARDS

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05166759
• Other study ID #: ARDS in the highland
• Status: Recruiting
• Start date: November 25, 2021
• Est. completion date: December 2022

Study information

• Verified date: November 2021
• Source: Southeast University, China
• Contact: Chun Pan, MD
• Phone: 13814009925
• Email: panchun1982[@]gmail.com
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

The study is conducted in the affiliated hospital of Qinghai University .Patients in the department of Critical Care Medicine and Emergency Intensive Care Unit will be eligible for inclusion if they meet the Berlin criteria.Two researchers assess pulmonary artery pressure and right heart function of patients who are enrolled.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 100
• Est. completion date: December 2022
• Est. primary completion date: March 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 80 Years

Eligibility

Inclusion Criteria:

Inclusion Criteria:

18 to 80 years of age Meet the diagnostic criteria Receive invasive mechanical ventilation within 48 hours

-

Exclusion Criteria:

Patients with those disease will be excluded : chronic obstructive pulmonary disease Pulmonary embolism Chronic heart failure Idiopathic pulmonary fibrosis Pulmonary hypertension Pregnant women will be excluded too.

-

Related Conditions & MeSH terms

• ARDS
• Hypertension
• Hypertension, Pulmonary

Intervention

Device:
• Doppler ultrasound
Pulmonary artery pressure and right heart function will be assessed using Doppler ultrasound

Locations

Country	Name	City	State
China	Affiliated Hospital of QingHai University	Xining	Qinghai

Sponsors (2)

Lead Sponsor	Collaborator
Southeast University, China	Qinghai University

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Right cardiac functionof Pulmonary Hypertension Secondary to ARDS in the Highland		20/11/2021-20/12/2022
Primary	Incidence of Pulmonary Hypertension Secondary to ARDS in the Highland		20/11/2021-20/12/2022
Primary	ICU mortality ICU mortality	Mortality during treatment in ICU	20/11/2021-20/12/2022
Primary	28-days mortality rate	Mortality at 28 days of hospitalization	20/11/2021-20/12/2022
Secondary	Ventilator time	Ventilator time in ICU	20/11/2021-20/12/2022
Secondary	Hospital length of stay	Total length of stay in hospital	20/11/2021-20/12/2022